Efficacy and safety analysis of bevacizumab combined with capecitabine in the maintenance treatment of RAS‐mutant metastatic colorectal cancer

WHAT IS KNOWN AND OBJECTIVES: The optimal strategy for maintenance therapy in patients with metastatic colorectal cancer (mCRC) remains controversial. Considering that, beyond progression, co‐therapy with bevacizumab and cytotoxic chemotherapy showed less toxicity and a significant disease control r...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Weizhen, Zhang, Hang, Tian, Yunming, Cha, Yinlian, Xiong, Hailin, Yuan, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306912/
https://www.ncbi.nlm.nih.gov/pubmed/35218209
http://dx.doi.org/10.1111/jcpt.13576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306912/
https://www.ncbi.nlm.nih.gov/pubmed/35218209
http://dx.doi.org/10.1111/jcpt.13576

Ejemplares similares